Margaux Faes
Mechelen-bovelingen, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Association between endo-histological outcomes and colonic mucosal transcriptomic profiles in patients with ulcerative colitis receiving filgotinib.
Journal: Journal of Crohn's & colitis
Published: January 22, 2026
Major adverse cardiovascular, thromboembolic and malignancy events in the filgotinib rheumatoid arthritis and ulcerative colitis clinical development programmes.
Journal: RMD open
Published: September 23, 2024
Long-term safety and efficacy of filgotinib for the treatment of moderately to severely active ulcerative colitis: Interim analysis from up to 4 years of follow-up in the SELECTION open-label long-term extension study.
Journal: Alimentary pharmacology & therapeutics
Published: February 20, 2024
Interactive medical and safety monitoring in clinical trials with clinDataReview: a validated and open-source reporting tool.
Journal: Frontiers in medicine
Published: December 15, 2023
Withdrawal and Re-treatment with Filgotinib in Ulcerative Colitis: Post Hoc Analyses of the Phase 2b/3 SELECTION and SELECTIONLTE Studies.
Journal: Journal of Crohn's & colitis
Published: August 04, 2023
Impact of Concomitant Thiopurine on the Efficacy and Safety of Filgotinib in Patients with Ulcerative Colitis: Post Hoc Analysis of the Phase 2b/3 SELECTION Study.
Journal: Journal of Crohn's & colitis
Published: June 25, 2023
Integrated safety analysis of filgotinib for ulcerative colitis: Results from SELECTION and SELECTIONLTE.
Journal: Alimentary pharmacology & therapeutics
Published: April 13, 2023
Filgotinib Improved Health-Related Quality of Life and Led to Comprehensive Disease Control in Individuals with Ulcerative Colitis: Data from the SELECTION Trial.
Journal: Journal of Crohn's & colitis
Published: February 09, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026